发明名称 MONOVALENT ANTIGEN BINDING CONSTRUCTS TARGETING EGFR AND/OR HER2 AND USES THEREOF
摘要 Provided herein are monovalent antigen-binding constructs targeting EGFR and/or HER2. The monovalent antigen-binding constructs can include at least one antigen-binding polypeptide comprising a heavy chain variable domain, wherein the antigen-bind polypeptide specifically binds EGFR and/or HER2; and a heterodimeric Fc domain, the Fc domain comprising at least two CH3 domains, wherein the Fc domain is coupled, with or without a linker, to the antigen-binding polypeptide. Also provided are methods of making the constructs and methods of using the constructs.
申请公布号 US2016289328(A1) 申请公布日期 2016.10.06
申请号 US201415036174 申请日期 2014.11.13
申请人 Zymeworks Inc. 发明人 NG Gordon Yiu Kon;CHAN Peter Wing Yiu;WICKMAN Grant Raymond
分类号 C07K16/28;C07K16/30;A61K47/48 主分类号 C07K16/28
代理机构 代理人
主权项 1. A method of treating a subject having an epidermal growth factor receptor (EGFR)-expressing tumor, comprising: contacting the tumor with an effective amount of an isolated monovalent EGFR-binding construct comprising at least one antigen-binding polypeptide comprising a heavy chain variable domain coupled, with or without a linker, to a heterodimeric Fc, wherein the antigen-binding polypeptide binds or specifically binds to EGFR, and wherein the construct binds to EGFR with a greater Bmax as compared to the corresponding isolated monospecific bivalent antigen-binding construct that binds or specifically binds EGFR.
地址 Vancouver CA